Name | 6,6,9-trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
---|---|
Synonyms |
KM-233
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-, (6aR,10aR)- (6aR,10aR)-6,6,9-Trimethyl-3-(2-phenyl-2-propanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol |
Description | KM-233 is a classical cannabinoid with good blood brain barrier penetration. KM-233 possesses a selective affinity for the CB2 receptors relative to THC. KM-233 is effective at reducing U87 glioma tumor burden, and can be used for glioma research[1]. |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 436.8±45.0 °C at 760 mmHg |
Molecular Formula | C25H30O2 |
Molecular Weight | 362.50 |
Flash Point | 171.9±23.0 °C |
Exact Mass | 362.224579 |
PSA | 29.46000 |
LogP | 7.63 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.560 |